HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carla Ghelardini Selected Research

Neuralgia (Stump Neuralgia)

6/2022Inhibitors of Mitochondrial Human Carbonic Anhydrases VA and VB as a Therapeutic Strategy against Paclitaxel-Induced Neuropathic Pain in Mice.
4/2022New Panx-1 Blockers: Synthesis, Biological Evaluation and Molecular Dynamic Studies.
1/2022Sultam based Carbonic Anhydrase VII inhibitors for the management of neuropathic pain.
1/2022Neuronal alarmin IL-1α evokes astrocyte-mediated protective signals: Effectiveness in chemotherapy-induced neuropathic pain.
12/2021Chalcogenides-incorporating carbonic anhydrase inhibitors concomitantly reverted oxaliplatin-induced neuropathy and enhanced antiproliferative action.
11/2021Design and synthesis of the first indole-based blockers of Panx-1 channel.
10/2021VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody.
10/2021The Histamine H4 Receptor Participates in the Anti-Neuropathic Effect of the Adenosine A3 Receptor Agonist IB-MECA: Role of CD4+ T Cells.
1/2021Carbonic Anhydrase IV Selective Inhibitors Counteract the Development of Colitis-Associated Visceral Pain in Rats.
1/2021Pain Relieving and Neuroprotective Effects of Non-opioid Compound, DDD-028, in the Rat Model of Paclitaxel-Induced Neuropathy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carla Ghelardini Research Topics

Disease

93Pain (Aches)
12/2022 - 10/2004
72Neuralgia (Stump Neuralgia)
06/2022 - 12/2002
38Hypersensitivity (Allergy)
04/2022 - 08/2006
32Neoplasms (Cancer)
04/2022 - 01/2013
32Hyperalgesia
01/2022 - 09/2002
15Inflammation (Inflammations)
08/2022 - 11/2007
12Colitis
08/2022 - 01/2019
11Rheumatoid Arthritis
10/2021 - 01/2013
11Osteoarthritis
08/2021 - 01/2013
8Visceral Pain
02/2022 - 12/2019
8Chronic Pain
02/2022 - 07/2013
8Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 03/2012
8Amnesia (Dissociative Amnesia)
04/2015 - 03/2002
7Painful Neuropathy
09/2018 - 06/2014
6Arthritis (Polyarthritis)
02/2022 - 01/2016
6Colonic Neoplasms (Colon Cancer)
02/2018 - 01/2014
6Peripheral Nervous System Diseases (PNS Diseases)
03/2017 - 01/2009
4Body Weight (Weight, Body)
08/2022 - 06/2010
4Epilepsy (Aura)
04/2022 - 05/2018
4Gliosis
02/2022 - 01/2013
4Abdominal Pain (Pain, Abdominal)
12/2020 - 12/2016
4Neuroblastoma
11/2019 - 10/2013
4Migraine Disorders (Migraine)
04/2013 - 09/2002
3Brain Ischemia (Cerebral Ischemia)
01/2022 - 12/2016
3Breast Neoplasms (Breast Cancer)
12/2021 - 11/2015
3Adenocarcinoma
08/2021 - 01/2018
3Cognitive Dysfunction
01/2020 - 03/2002
3Pancreatic Neoplasms (Pancreatic Cancer)
03/2019 - 01/2016
3Wounds and Injuries (Trauma)
01/2019 - 07/2013
3Mononeuropathies (Mononeuritis Multiplex)
01/2019 - 04/2011
3Hypoxia (Hypoxemia)
12/2018 - 05/2015
3Neoplasm Metastasis (Metastasis)
09/2018 - 05/2015
3Edema (Dropsy)
10/2016 - 08/2008

Drug/Important Bio-Agent (IBA)

53Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2022 - 05/2010
23Carbonic Anhydrases (Carbonic Anhydrase)IBA
06/2022 - 04/2015
22Pharmaceutical PreparationsIBA
08/2021 - 10/2004
20Morphine (MS Contin)FDA LinkGeneric
10/2021 - 09/2002
18Protein Isoforms (Isoforms)IBA
12/2021 - 04/2015
14Opioid Analgesics (Opioids)IBA
02/2022 - 09/2004
112,4-dinitrofluorobenzene sulfonic acidIBA
08/2022 - 12/2019
11Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2021 - 01/2009
10Proteins (Proteins, Gene)FDA Link
04/2022 - 10/2009
10Analgesics (Analgesic Drugs)IBA
01/2021 - 09/2002
9AntioxidantsIBA
06/2021 - 11/2011
8LigandsIBA
01/2022 - 12/2011
7Carbonic Anhydrase InhibitorsIBA
05/2021 - 04/2015
6CarrageenanIBA
04/2022 - 08/2008
6Streptozocin (Streptozotocin)FDA Link
12/2021 - 03/2008
6PlatinumIBA
12/2021 - 11/2014
6Antineoplastic Agents (Antineoplastics)IBA
12/2021 - 07/2013
6SulfonamidesIBA
11/2019 - 04/2015
6Acetylcarnitine (Alcar)IBA
04/2018 - 12/2002
6SodiumIBA
12/2017 - 04/2011
5Paclitaxel (Taxol)FDA LinkGeneric
06/2022 - 11/2015
5Biological ProductsIBA
12/2021 - 03/2008
5Purinergic P1 Receptors (Adenosine Receptor)IBA
10/2021 - 01/2019
5BenzenesulfonamidesIBA
01/2021 - 06/2018
5EnzymesIBA
01/2021 - 10/2009
5Freund's AdjuvantIBA
06/2019 - 01/2013
5isothiocyanic acidIBA
03/2019 - 11/2016
5N-Methylaspartate (NMDA)IBA
07/2015 - 12/2002
5Protein Kinase CIBA
04/2013 - 08/2004
4Sulfonic AcidsIBA
08/2022 - 01/2020
4Potassium Channels (Potassium Channel)IBA
02/2022 - 11/2016
4GlucosinolatesIBA
02/2022 - 11/2018
4AcidsIBA
01/2022 - 10/2009
4Glutamic Acid (Glutamate)FDA Link
01/2022 - 11/2014
4N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA
01/2022 - 01/2020
42,4-dinitrobenzenesulfonic acidIBA
01/2022 - 01/2020
4Carbonic Anhydrase IXIBA
12/2021 - 11/2017
4Thioctic Acid (Lipoic Acid)IBA
01/2021 - 01/2013
4Neuroprotective AgentsIBA
01/2021 - 01/2009
4Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
12/2020 - 01/2017
4Opioid Receptors (Opioid Receptor)IBA
01/2020 - 11/2014
4Pregabalin (Lyrica)FDA Link
06/2019 - 04/2011
4Caffeine (No Doz)FDA LinkGeneric
01/2019 - 09/2002
4Gabapentin (Neurontin)FDA LinkGeneric
04/2018 - 07/2015
4dimiracetamIBA
12/2017 - 03/2008
4Indomethacin (Indometacin)FDA LinkGeneric
01/2017 - 09/2002
4Scopolamine (Hyoscine)FDA Link
04/2015 - 03/2002
32,4-dinitrobenzeneIBA
08/2022 - 01/2020
3Dexamethasone (Maxidex)FDA LinkGeneric
05/2022 - 01/2020
3Cadmium Chloride (Cadmium Dichloride)IBA
01/2022 - 04/2018
3S-(2-guanidylethyl)isothioureaIBA
10/2021 - 08/2013
3IsothiocyanatesIBA
04/2021 - 07/2017
3Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2021 - 04/2013
3Ibuprofen (Motrin)FDA LinkGeneric
06/2019 - 07/2015
3ProdrugsIBA
12/2018 - 02/2012
3Superoxide DismutaseIBA
11/2018 - 11/2011
3NociceptinIBA
03/2018 - 11/2015
3Histamine H4 ReceptorsIBA
01/2017 - 08/2013
3Dizocilpine Maleate (Dizocilpine)IBA
07/2015 - 08/2006
3Nootropic Agents (Nootropics)IBA
04/2015 - 03/2008

Therapy/Procedure

30Therapeutics
02/2022 - 11/2011
21Drug Therapy (Chemotherapy)
01/2022 - 07/2013
8Analgesia
01/2020 - 06/2003
6Intra-Articular Injections
01/2018 - 04/2011
5Ligation
01/2021 - 01/2009
5Oral Administration
12/2020 - 04/2011
4Aftercare (After-Treatment)
12/2017 - 05/2014